Vertex Pharmaceuticals Inc. sell Canaccord Genuity Group Inc.
Start price
24.01.24
/
50%
€401.90
Target price
24.01.25
€346.79
Performance (%)
3.27%
Price
17:24
€415.05
Summary
This prediction is currently active. The SELL prediction by Canaccord_Genuity_Gr shows the price for Vertex Pharmaceuticals Inc. has slightly increased by 3.27%. This prediction currently runs until 24.01.25. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | -0.772% | -0.772% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "sell" rating. They now have a $379.00 price target on the stock, up previously from $332.00.
Ratings data for VRTX provided by MarketBeat